Previous studies have suggested that TGF-β-induced EMT confer GC cells resistance to 5-FU36,37, and suppression of EMT via diverse approaches increased the sensitivity to 5-FU-based chemotherapy in GC38,39. This evidence concerns the gene TGFB1 and gastric cancer.